(Q30668690)

26 June 2017

0 references

Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies (English)

1 reference

26 June 2017

main subject

arterial hypertension

1 reference

P Weidmann

1

1 reference

26 June 2017

publication date

1 January 2001

1 reference

26 June 2017

1 reference

26 June 2017

volume

24

1 reference

26 June 2017

issue

15

1 reference

26 June 2017

page(s)

1155-1165

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200124150-00006

26 June 2017

exact match

0 references

cites work

Requirements for antihypertensive therapy in diabetic patients: metabolic aspects

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study.

1 reference

12 December 2020

Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension

1 reference

12 December 2020

Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis

1 reference

12 December 2020

Long-term effects of indapamide: final results of a two-year Italian multicenter study in systemic hypertension

1 reference

12 December 2020

Antihypertensive therapy in diabetic patients. The use of indapamide

1 reference

12 December 2020

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee

1 reference

12 December 2020

Adverse metabolic effects of antihypertensive drugs. Implications for treatment

1 reference

12 December 2020

Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up

1 reference

12 December 2020

Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?

1 reference

12 December 2020

The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics

1 reference

12 December 2020

Indapamide in the treatment of hypertension in non-insulin-dependent diabetes.

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

12 December 2020

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperat

1 reference

12 December 2020

Long-Term Epidemiologic Prediction of Coronary Disease

1 reference

12 December 2020

Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study

1 reference

12 December 2020

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

12 December 2020

Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Tolerability and well-being with indapamide in the treatment of mild-moderate hypertension. An Italian multicenter study

1 reference

12 December 2020

Beneficial effects of indapamide on lipoproteins and apoproteins in ambulatory hypertensive patients

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Cardiovascular protective properties of indapamide

1 reference

12 December 2020

Changes in vascular reactivity in experimental hypertensive animals following treatment with indapamide

1 reference

12 December 2020

Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension.

1 reference

12 December 2020

Correction of altered noradrenaline reactivity in essential hypertension by indapamide

1 reference

12 December 2020

Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension

1 reference

12 December 2020

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

12 December 2020

A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides

1 reference

12 December 2020

Do different hemodynamic effects of antihypertensive drugs translate into different safety profiles?

1 reference

12 December 2020

Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.

1 reference

12 December 2020

Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects

1 reference

12 December 2020

Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group

1 reference

12 December 2020

Influence of diuretics, calcium antagonists, and alpha-blockers on insulin sensitivity and glucose tolerance in hypertensive patients

1 reference

12 December 2020

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study

1 reference

12 December 2020

Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers.

1 reference

12 December 2020

Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies

1 reference

12 December 2020

Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension

1 reference

12 December 2020

Antihypertensive agents, serum lipoproteins and glucose metabolism

1 reference

12 December 2020

10.2165/00002018-200124150-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

26 June 2017

1042301611

0 references

1 reference